BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17666964)

  • 21. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.
    Rosen S; Ketlhapile M; Sanne I; Desilva MB
    AIDS; 2008 Jul; 22 Suppl 1():S131-9. PubMed ID: 18664945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
    Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
    Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
    HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and outcomes of paediatric antiretroviral treatment in South Africa.
    Meyer-Rath G; Brennan A; Long L; Ndibongo B; Technau K; Moultrie H; Fairlie L; Coovadia A; Rosen S
    AIDS; 2013 Jan; 27(2):243-50. PubMed ID: 23014517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
    Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
    Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.
    Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Sathapatayavongs B
    Int J STD AIDS; 2007 Dec; 18(12):832-4. PubMed ID: 18073016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using a file audit to evaluate retention in care and patient outcomes in a programme to decentralise antiretroviral treatment to primary health care facilities in a high prevalence setting in KwaZulu-Natal, South Africa.
    Searle C; Ramkissoon A; Govender T
    Stud Health Technol Inform; 2010; 160(Pt 1):476-80. PubMed ID: 20841732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
    Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
    Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.
    Fielding KL; Charalambous S; Stenson AL; Pemba LF; Martin DJ; Wood R; Churchyard GJ; Grant AD
    BMC Infect Dis; 2008 Jul; 8():93. PubMed ID: 18631397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and loss to follow-up among HAART initiators in rural South Africa.
    MacPherson P; Moshabela M; Martinson N; Pronyk P
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):588-93. PubMed ID: 19012940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
    Leisegang R; Cleary S; Hislop M; Davidse A; Regensberg L; Little F; Maartens G
    PLoS Med; 2009 Dec; 6(12):e1000189. PubMed ID: 19956658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
    Boulle A; Kenyon C; Skordis J; Wood R
    S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The introduction of antiretroviral therapy in Malawi].
    Zijlstra EE; van Oosterhout JJ
    Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.